Cargando…
High frequency hearing thresholds and product distortion otoacoustic emissions in cystic fibrosis patients()()
INTRODUCTION: The treatment of patients with cystic fibrosis involves the use of ototoxic drugs, mainly aminoglycoside antibiotics. Due to the use of these drugs, fibrocystic patients are at risk of developing hearing loss. OBJECTIVE: To evaluate the hearing of patients with cystic fibrosis by High...
Autores principales: | Geyer, Lucia Bencke, Menna Barreto, Sergio Saldanha, Weigert, Liese Loureiro, Teixeira, Adriane Ribeiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9442703/ https://www.ncbi.nlm.nih.gov/pubmed/26480907 http://dx.doi.org/10.1016/j.bjorl.2015.08.011 |
Ejemplares similares
-
Hearing thresholds at high frequency in patients with cystic fibrosis: a systematic review()
por: Caumo, Debora T.M., et al.
Publicado: (2016) -
Erratum of “Hearing thresholds at high frequency in patients with cystic fibrosis: a systematic review”()
por: Caumo, Debora T.M., et al.
Publicado: (2017) -
Estimating Hearing Thresholds From Stimulus-Frequency Otoacoustic Emissions
por: Gong, Qin, et al.
Publicado: (2020) -
Evaluation of Distortion and Transient Evoked Otoacoustic Emission in Tinnitus Patients with Normal Hearing
por: Mokrian, Helnaz, et al.
Publicado: (2014) -
The Effect of Stimuli Level on Distortion Product Otoacoustic Emission in Normal Hearing Adults
por: Naghibolhosseini, Maryam
Publicado: (2023)